Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cashflow Statement

INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹-104 Cr₹-75 Cr₹124 Cr₹193 Cr₹237 Cr
Adjustment ₹250 Cr₹184 Cr₹138 Cr₹121 Cr₹87 Cr
Changes In working Capital ₹55 Cr₹2.79 Cr₹-88 Cr₹-73 Cr₹-109 Cr
Cash Flow after changes in Working Capital ₹201 Cr₹111 Cr₹173 Cr₹240 Cr₹215 Cr
Cash Flow from Operating Activities ₹192 Cr₹95 Cr₹155 Cr₹179 Cr₹174 Cr
Cash Flow from Investing Activities ₹-102 Cr₹-339 Cr₹-433 Cr₹-208 Cr₹-121 Cr
Cash Flow from Financing Activities ₹-77 Cr₹241 Cr₹280 Cr₹23 Cr₹-44 Cr
Net Cash Inflow / Outflow ₹14 Cr₹-2.75 Cr₹3.31 Cr₹-6.54 Cr₹8.05 Cr
Opening Cash & Cash Equivalents ₹12 Cr₹15 Cr₹11 Cr₹17 Cr₹9.42 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations --₹0.62 Cr--
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹26 Cr₹12 Cr₹15 Cr₹11 Cr₹17 Cr

Compare Cashflow Statement of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,299.2 Cr -1.1% 6.3% -16.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,478.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹253,031.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,216.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,205.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹102,040.0 Cr 0.1% 1.4% -9.3% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-1.1%

6.3%

-16.8%

SENSEX

-2.8%

-6.1%

-11.9%


You may also like the below Video Courses